New approaches to COPD
No currently available treatments reduce the progression or suppress the inflammation of chronic obstructive pulmonary disease (COPD). However, with a better understanding of the inflammatory and destructive process, several targets have been identified, and new treatments are now in clinical develo...
Main Author: | P. J. Barnes |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2005-09-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/14/94/2 |
Similar Items
-
Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin
by: Alexandre Sampaio Moura, et al.
Published: (2011-02-01) -
Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
by: Bethan Dalton, et al.
Published: (2018-10-01) -
A Patient with Rheumatoid Arthritis under Methotrexate and Etanercept Treatment Presenting with Fever and Pancytopenia: An Unexpected Guest
by: Dimitrios Patoulias, et al.
Published: (2021-01-01) -
Time and Concentration Dependent Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Induced Endothelial Activation
by: Meng Li, et al.
Published: (2018-03-01) -
Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
by: Asad Aziz Khan, et al.
Published: (2020-12-01)